The Consortium for Metabonomic Toxicology (COMET): Aims, Activities and Achievements
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The utility of metabonomics in the evaluation of xenobiotic toxicity has been comprehensively assessed by the Consortium for Metabonomic Toxicology (COMET), formed between five major pharmaceutical companies and Imperial College London, UK. The main objectives were to assess methodologies, to generate a metabonomic database using (1)H nuclear magnetic resonance (NMR) spectroscopy of rodent urine and blood serum and to build a predictive expert system for target organ toxicity. The analytic and biologic variation that might arise through the use of metabonomics was evaluated and a high degree of robustness demonstrated. With the completion of 147 studies, the chief deliverables of a curated database of rodent biofluid NMR spectra and computer-based expert systems for the prediction of kidney or liver toxicity in rat and mouse based on the spectral data have been generated, and delivered to the sponsoring companies. The project, with its relatively modest resources, has met and exceeded all of its targets and was judged a resounding success by the sponsoring companies who are, in many cases, already enhancing and making use of the data in their in-house studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabonomics: a platform for studying drug toxicity and gene function
Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd728 · Cited by 1,914
Self-citationMultiple-laboratory comparison of microarray platforms
Irizarry, R. A., Warren, D., Spencer, F., Kim, I. F., Biswal, S., Frank, B. C., Gabrielson, E., Garcia, J. G. N., Geoghegan, J., Germino, G., et al. (2005) · Nature Methods · doi:10.1038/nmeth756 · Cited by 862 · cited 1×
“These conclusions have been supported by recent comprehensive publications of microarray interplatform and intersite reproducibility [18–20].”
Standardizing global gene expression analysis between laboratories and across platforms
Members of the Toxicogenomics Research Consortium (2005) · Nature Methods · doi:10.1038/nmeth754 · Cited by 465
Independence and reproducibility across microarray platforms
Larkin, J. E., Frank, B. C., Gavras, H., Sultana, R., & Quackenbush, J. (2005) · Nature Methods · doi:10.1038/nmeth757 · Cited by 421
Aardema, M. J., & MacGregor, J. T. (2002) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00292-5 · Cited by 389
Lindon, J. C., Nicholson, J. K., Holmes, E., Antti, H., Bollard, M. E., Keun, H., Beckonert, O., Ebbels, T. M., Reily, M. D., Robertson, D., et al. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(02)00079-0 · Cited by 385
Self-citationA proposed framework for the description of plant metabolomics experiments and their results
Jenkins, H., Hardy, N., Beckmann, M., Draper, J., Smith, A. R., Taylor, J., Fiehn, O., Goodacre, R., Bino, R. J., Hall, R., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt1041 · Cited by 285
Chemometric Models for Toxicity Classification Based on NMR Spectra of Biofluids
Holmes, E., Nicholls, A. W., Lindon, J. C., Connor, S. C., Connelly, J. C., Haselden, J. N., Damment, S. J. P., Spraul, M., Neidig, P., & Nicholson, J. K. (2000) · Chemical Research in Toxicology · doi:10.1021/tx990210t · Cited by 276
Self-citationSummary recommendations for standardization and reporting of metabolic analyses
The Standard Metabolic Reporting Structures working group (2005) · Nature Biotechnology · doi:10.1038/nbt0705-833 · Cited by 275
Analytical Reproducibility in 1H NMR-Based Metabonomic Urinalysis
Keun, H. C., Ebbels, T. M. D., Antti, H., Bollard, M. E., Beckonert, O., Schlotterbeck, G., Senn, H., Niederhauser, U., Holmes, E., Lindon, J. C., et al. (2002) · Chemical Research in Toxicology · doi:10.1021/tx0255774 · Cited by 247
Self-citationCheng, L. L., Chang, I. W., Louis, D. N., & González, R. G. (1998) · PubMed · Cited by 208
Invited Review: Toxicoproteomics: Proteomics Applied to Toxicology and Pathology
Wetmore, B. A., & Merrick, B. A. (2004) · Toxicologic Pathology · doi:10.1080/01926230490518244 · Cited by 205
Metabonomic Investigations into Hydrazine Toxicity in the Rat
Nicholls, A. W., Holmes, E., Lindon, J. C., Shockcor, J. P., Farrant, R. D., Haselden, J. N., Damment, S. J. P., Waterfield, C. J., & Nicholson, J. K. (2001) · Chemical Research in Toxicology · doi:10.1021/tx000231j · Cited by 194
Self-citationKeun, H. C., Ebbels, T. M. D., Antti, H., Bollard, M. E., Beckonert, O., Holmes, E., Lindon, J. C., & Nicholson, J. K. (2003) · Analytica Chimica Acta · doi:10.1016/s0003-2670(03)00094-1 · Cited by 192
Self-citationToxicological applications of magnetic resonance
Lindon, J. C., Holmes, E. C., & Nicholson, J. K. (2004) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2004.05.001 · Cited by 138
Self-citationMetabolomics in the Opening Decade of the 21st Century: Building the Roads to Individualized Health
German, J. B., Bauman, D. E., Burrin, D. G., Failla, M. L., Freake, H. C., King, J. C., Klein, S., Milner, J. A., Pelto, G. H., Rasmussen, K. M., et al. (2004) · Journal of Nutrition · doi:10.1093/jn/134.10.2729 · Cited by 94
Ulrich, R. G., Rockett, J. C., Gibson, G. G., & Pettit, S. D. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.6675 · Cited by 78
Toxicity classification from metabonomic data using a density superposition approach: ‘CLOUDS’
Ebbels, T. M. D., Keun, H. C., Beckonert, O. P., Antti, H., Bollard, M. E., Holmes, E. C., Lindon, J. C., & Nicholson, J. K. (2003) · Analytica Chimica Acta · doi:10.1016/s0003-2670(03)00121-1 · Cited by 73
Self-citationHayes, K. R., Vollrath, A. L., Zastrow‐Hayes, G., McMillan, B. J., Craven, M. W., Jovanovich, S. B., Rank, D. R., Penn, S., Walisser, J. A., Reddy, J. K., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009175 · Cited by 67
Metabonomics in Toxicity Assessment
(2005) · CRC Press eBooks · doi:10.1201/b14117 · Cited by 64
CEBS object model for systems biology data, SysBio-OM
Xirasagar, S., Gustafson, S. F., Merrick, B. A., Tomer, K. B., Stasiewicz, S., Chan, D. D., Yost, K. J., Yates, J. R., Sumner, S., Xiao, N., et al. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth189 · Cited by 63
Cross-site comparison of gene expression data reveals high similarity.
Chu, T., Deng, S., Wolfinger, R. D., Paules, R. S., & Hamadeh, H. K. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.6787 · Cited by 48
Granger, J. H., Plumb, R. S., Castro‐Perez, J. M., & Wilson, I. D. (2005) · Chromatographia · doi:10.1365/s10337-005-0523-x · Cited by 35
Cited by
The Human Serum Metabolome (HUSERMET) Consortium, Dunn, W. B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIntyre, S., Anderson, N., Brown, M., Knowles, J. D., Halsall, A., et al. (2011) · Nature Protocols · doi:10.1038/nprot.2011.335 · Cited by 3,294
Beckonert, O., Keun, H. C., Ebbels, T. M. D., Bundy, J., Holmes, E., Lindon, J. C., & Nicholson, J. K. (2007) · Nature Protocols · doi:10.1038/nprot.2007.376 · Cited by 2,109
Self-citationEmerging applications of metabolomics in drug discovery and precision medicine
Wishart, D. S. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.32 · Cited by 1,488
Bouatra, S., Aziat, F., Mandal, R., Guo, A. C., Wilson, M. R., Knox, C., Bjorndahl, T. C., Krishnamurthy, R., Saleem, F., Liu, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073076 · Cited by 1,449
Dunn, W. B., Broadhurst, D. I., Atherton, H. J., Goodacre, R., & Griffin, J. L. (2011) · Chem. Soc. Rev. · doi:10.1039/b906712b · Cited by 860
Metadata
- Authors
- Lindon, J. C., Keun, H. C., Ebbels, T. M., Pearce, J. M., Holmes, E., & Nicholson, J. K.
- Venue
- Pharmacogenomics
- Publisher
- Informa UK Limited
- Published
- 2005-10
- Volume
- 6
- Issue
- 7
- Pages
- 691-699
- ISSN
- 1462-2416 (ISSN-L)
- 1744-8042
- OpenAlex
- W2123934362
- Cited by
- 275
- References
- 23
- FWCI
- 8.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.